Table of Contents EMEA (Europe, Middle East and Africa) RNA-based Biopharmaceuticals Market Report 2018 1 RNA-based Biopharmaceuticals Overview 1.1 Product Overview and Scope of RNA-based Biopharmaceuticals 1.2 Classification of RNA-based Biopharmaceuticals 1.2.1 EMEA RNA-based Biopharmaceuticals Market Size (Sales) Comparison by Type (2013-2025) 1.2.2 EMEA RNA-based Biopharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Therapeutics 1.2.4 Vaccines 1.3 EMEA RNA-based Biopharmaceuticals Market by Application/End Users 1.3.1 EMEA RNA-based Biopharmaceuticals Sales (Volume) and Market Share Comparison by Application (2013-2025) 1.3.2 Cancer 1.3.3 Diabetes 1.3.4 Tuberculosis 1.3.5 Cardiovascular Diseases 1.3.6 Others 1.4 EMEA RNA-based Biopharmaceuticals Market by Region 1.4.1 EMEA RNA-based Biopharmaceuticals Market Size (Value) Comparison by Region (2013-2025) 1.4.2 Europe Status and Prospect (2013-2025) 1.4.3 Middle East Status and Prospect (2013-2025) 1.4.4 Africa Status and Prospect (2013-2025) 1.5 EMEA Market Size (Value and Volume) of RNA-based Biopharmaceuticals (2013-2025) 1.5.1 EMEA RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2025) 1.5.2 EMEA RNA-based Biopharmaceuticals Revenue and Growth Rate (2013-2025) 2 EMEA RNA-based Biopharmaceuticals Competition by Manufacturers/Players/Suppliers, Region, Type and Application 2.1 EMEA RNA-based Biopharmaceuticals Market Competition by Players/Manufacturers 2.1.1 EMEA RNA-based Biopharmaceuticals Sales Volume and Market Share of Major Players (2013-2018) 2.1.2 EMEA RNA-based Biopharmaceuticals Revenue and Share by Players (2013-2018) 2.1.3 EMEA RNA-based Biopharmaceuticals Sale Price by Players (2013-2018) 2.2 EMEA RNA-based Biopharmaceuticals (Volume and Value) by Type/Product Category 2.2.1 EMEA RNA-based Biopharmaceuticals Sales and Market Share by Type (2013-2018) 2.2.2 EMEA RNA-based Biopharmaceuticals Revenue and Market Share by Type (2013-2018) 2.2.3 EMEA RNA-based Biopharmaceuticals Sale Price by Type (2013-2018) 2.3 EMEA RNA-based Biopharmaceuticals (Volume) by Application 2.4 EMEA RNA-based Biopharmaceuticals (Volume and Value) by Region 2.4.1 EMEA RNA-based Biopharmaceuticals Sales and Market Share by Region (2013-2018) 2.4.2 EMEA RNA-based Biopharmaceuticals Revenue and Market Share by Region (2013-2018) 2.4.3 EMEA RNA-based Biopharmaceuticals Sales Price by Region (2013-2018) 3 Europe RNA-based Biopharmaceuticals (Volume, Value and Sales Price), by Players, Countries, Type and Application 3.1 Europe RNA-based Biopharmaceuticals Sales and Value (2013-2018) 3.1.1 Europe RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2013-2018) 3.1.2 Europe RNA-based Biopharmaceuticals Revenue and Growth Rate (2013-2018) 3.2 Europe RNA-based Biopharmaceuticals Sales and Market Share by Type 3.3 Europe RNA-based Biopharmaceuticals Sales and Market Share by Application 3.4 Europe RNA-based Biopharmaceuticals Sales Volume and Value (Revenue) by Countries 3.4.1 Europe RNA-based Biopharmaceuticals Sales Volume by Countries (2013-2018) 3.4.2 Europe RNA-based Biopharmaceuticals Revenue by Countries (2013-2018) 3.4.3 Germany RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 3.4.4 France RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 3.4.5 UK RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 3.4.6 Russia RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 3.4.7 Italy RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 3.4.8 Benelux RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 4 Middle East RNA-based Biopharmaceuticals (Volume, Value and Sales Price), by Region, Type and Application 4.1 Middle East RNA-based Biopharmaceuticals Sales and Value (2013-2018) 4.1.1 Middle East RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2013-2018) 4.1.2 Middle East RNA-based Biopharmaceuticals Revenue and Growth Rate (2013-2018) 4.2 Middle East RNA-based Biopharmaceuticals Sales and Market Share by Type 4.3 Middle East RNA-based Biopharmaceuticals Sales and Market Share by Application 4.4 Middle East RNA-based Biopharmaceuticals Sales Volume and Value (Revenue) by Countries 4.4.1 Middle East RNA-based Biopharmaceuticals Sales Volume by Countries (2013-2018) 4.4.2 Middle East RNA-based Biopharmaceuticals Revenue by Countries (2013-2018) 4.4.3 Saudi Arabia RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 4.4.4 Israel RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 4.4.5 UAE RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 4.4.6 Iran RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 5 Africa RNA-based Biopharmaceuticals (Volume, Value and Sales Price) by Players, Countries, Type and Application 5.1 Africa RNA-based Biopharmaceuticals Sales and Value (2013-2018) 5.1.1 Africa RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2013-2018) 5.1.2 Africa RNA-based Biopharmaceuticals Revenue and Growth Rate (2013-2018) 5.2 Africa RNA-based Biopharmaceuticals Sales and Market Share by Type 5.3 Africa RNA-based Biopharmaceuticals Sales and Market Share by Application 5.4 Africa RNA-based Biopharmaceuticals Sales Volume and Value (Revenue) by Countries 5.4.1 Africa RNA-based Biopharmaceuticals Sales Volume by Countries (2013-2018) 5.4.2 Africa RNA-based Biopharmaceuticals Revenue by Countries (2013-2018) 5.4.3 South Africa RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 5.4.4 Nigeria RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 5.4.5 Egypt RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 5.4.6 Algeria RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2018) 6 EMEA RNA-based Biopharmaceuticals Manufacturers/Players Profiles and Sales Data 6.1 Pfizer 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 RNA-based Biopharmaceuticals Product Type, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 Roche 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 RNA-based Biopharmaceuticals Product Type, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 Sanofi-Aventis 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 RNA-based Biopharmaceuticals Product Type, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Abbott Laboratories 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 RNA-based Biopharmaceuticals Product Type, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 Arrowhead Pharmaceuticals 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 RNA-based Biopharmaceuticals Product Type, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 Benitec Biopharma 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 RNA-based Biopharmaceuticals Product Type, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 Calimmune Inc 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 RNA-based Biopharmaceuticals Product Type, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview 6.8 Dicerna 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 RNA-based Biopharmaceuticals Product Type, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.8.4 Main Business/Business Overview 6.9 Gradalis 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 RNA-based Biopharmaceuticals Product Type, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.9.4 Main Business/Business Overview 6.10 Quark 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 RNA-based Biopharmaceuticals Product Type, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.10.4 Main Business/Business Overview 6.11 RXi 6.12 Senesco 6.13 Silence Therapeutics 6.14 Silenseed 6.15 Tekmira 6.16 Alnylam Pharmaceuticals 7 RNA-based Biopharmaceuticals Manufacturing Cost Analysis 7.1 RNA-based Biopharmaceuticals Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 RNA-based Biopharmaceuticals Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of RNA-based Biopharmaceuticals Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 EMEA RNA-based Biopharmaceuticals Market Forecast (2018-2025) 11.1 EMEA RNA-based Biopharmaceuticals Sales, Revenue and Price Forecast (2018-2025) 11.1.1 EMEA RNA-based Biopharmaceuticals Sales and Growth Rate Forecast (2018-2025) 11.1.2 EMEA RNA-based Biopharmaceuticals Revenue and Growth Rate Forecast (2018-2025) 11.1.3 EMEA RNA-based Biopharmaceuticals Price and Trend Forecast (2018-2025) 11.2 EMEA RNA-based Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.3 Europe RNA-based Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.4 Middle Eastt RNA-based Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.5 Africa RNA-based Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.6 EMEA RNA-based Biopharmaceuticals Sales Forecast by Type (2018-2025) 11.7 EMEA RNA-based Biopharmaceuticals Sales Forecast by Application (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of RNA-based Biopharmaceuticals Figure EMEA RNA-based Biopharmaceuticals Sales Volume (K Units) by Type (2013-2025) Figure EMEA RNA-based Biopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2017 Figure Therapeutics Product Picture Figure Vaccines Product Picture Figure EMEA RNA-based Biopharmaceuticals Sales Volume (K Units) by Application (2013-2025) Figure EMEA Sales Market Share of RNA-based Biopharmaceuticals by Application in 2017 Figure Cancer Examples Table Key Downstream Customer in Cancer Figure Diabetes Examples Table Key Downstream Customer in Diabetes Figure Tuberculosis Examples Table Key Downstream Customer in Tuberculosis Figure Cardiovascular Diseases Examples Table Key Downstream Customer in Cardiovascular Diseases Figure Others Examples Table Key Downstream Customer in Others Figure EMEA RNA-based Biopharmaceuticals Market Size (Million USD) by Region (2013-2025) Figure Europe RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure Europe RNA-based Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries Figure Middle East RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure Middle East RNA-based Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries Figure Africa RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure Africa RNA-based Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries Figure EMEA RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2013-2025) Figure EMEA RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure EMEA RNA-based Biopharmaceuticals Market Major Players Product Sales Volume (K Units) (2013-2018) Table EMEA RNA-based Biopharmaceuticals Sales Volume (K Units) of Major Players (2013-2018) Table EMEA RNA-based Biopharmaceuticals Sales Share by Players (2013-2018) Figure 2017 RNA-based Biopharmaceuticals Sales Share by Players Figure 2017 RNA-based Biopharmaceuticals Sales Share by Players Figure EMEA RNA-based Biopharmaceuticals Market Major Players Product Revenue (Million USD) (2013-2018) Table EMEA RNA-based Biopharmaceuticals Revenue (Million USD) by Players (2013-2018) Table EMEA RNA-based Biopharmaceuticals Revenue Share by Players (2013-2018) Table 2017 EMEA RNA-based Biopharmaceuticals Revenue Share by Players Table 2017 EMEA RNA-based Biopharmaceuticals Revenue Share by Players Table EMEA RNA-based Biopharmaceuticals Sale Price (USD/Unit) by Players (2013-2018) Table EMEA RNA-based Biopharmaceuticals Sales (K Units) and Market Share by Type (2013-2018) Table EMEA RNA-based Biopharmaceuticals Sales Share by Type (2013-2018) Figure Sales Market Share of RNA-based Biopharmaceuticals by Type (2013-2018) Figure EMEA RNA-based Biopharmaceuticals Sales Market Share by Type (2013-2018) Table EMEA RNA-based Biopharmaceuticals Revenue (Million USD) and Market Share by Type (2013-2018) Table EMEA RNA-based Biopharmaceuticals Revenue Share by Type (2013-2018) Figure Revenue Market Share of RNA-based Biopharmaceuticals by Type in 2017 Table EMEA RNA-based Biopharmaceuticals Sale Price (USD/Unit) by Type (2013-2018) Table EMEA RNA-based Biopharmaceuticals Sales (K Units) and Market Share by Application (2013-2018) Table EMEA RNA-based Biopharmaceuticals Sales Share by Application (2013-2018) Figure Sales Market Share of RNA-based Biopharmaceuticals by Application (2013-2018) Figure EMEA RNA-based Biopharmaceuticals Sales Market Share by Application in 2017 Table EMEA RNA-based Biopharmaceuticals Sales (K Units) and Market Share by Region (2013-2018) Table EMEA RNA-based Biopharmaceuticals Sales Share by Region (2013-2018) Figure Sales Market Share of RNA-based Biopharmaceuticals by Region (2013-2018) Figure EMEA RNA-based Biopharmaceuticals Sales Market Share in 2017 Table EMEA RNA-based Biopharmaceuticals Revenue (Million USD) and Market Share by Region (2013-2018) Table EMEA RNA-based Biopharmaceuticals Revenue Share by Region (2013-2018) Figure Revenue Market Share of RNA-based Biopharmaceuticals by Region (2013-2018) Figure EMEA RNA-based Biopharmaceuticals Revenue Market Share Regions in 2017 Table EMEA RNA-based Biopharmaceuticals Sales Price (USD/Unit) by Region (2013-2018) Figure Europe RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Europe RNA-based Biopharmaceuticals Revenue and Growth Rate (2013-2018) Table Europe RNA-based Biopharmaceuticals Sales (K Units) by Type (2013-2018) Table Europe RNA-based Biopharmaceuticals Market Share by Type (2013-2018) Figure Europe RNA-based Biopharmaceuticals Market Share by Type in 2017 Table Europe RNA-based Biopharmaceuticals Sales (K Units) by Application (2013-2018) Table Europe RNA-based Biopharmaceuticals Market Share by Application (2013-2018) Figure Europe RNA-based Biopharmaceuticals Market Share by Application in 2017 Table Europe RNA-based Biopharmaceuticals Sales (K Units) by Countries (2013-2018) Table Europe RNA-based Biopharmaceuticals Sales Market Share by Countries (2013-2018) Figure Europe RNA-based Biopharmaceuticals Sales Market Share by Countries (2013-2018) Figure Europe RNA-based Biopharmaceuticals Sales Market Share by Countries in 2017 Table Europe RNA-based Biopharmaceuticals Revenue (Million USD) by Countries (2013-2018) Table Europe RNA-based Biopharmaceuticals Revenue Market Share by Countries (2013-2018) Figure Europe RNA-based Biopharmaceuticals Revenue Market Share by Countries (2013-2018) Figure Europe RNA-based Biopharmaceuticals Revenue Market Share by Countries in 2017 Figure Germany RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure France RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure UK RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Russia RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Italy RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Benelux RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Middle East RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Middle East RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2018) Table Middle East RNA-based Biopharmaceuticals Sales (K Units) by Type (2013-2018) Table Middle East RNA-based Biopharmaceuticals Market Share by Type (2013-2018) Figure Middle East RNA-based Biopharmaceuticals Market Share by Type (2013-2018) Table Middle East RNA-based Biopharmaceuticals Sales (K Units) by Applications (2013-2018) Table Middle East RNA-based Biopharmaceuticals Market Share by Applications (2013-2018) Figure Middle East RNA-based Biopharmaceuticals Sales Market Share by Application in 2017 Table Middle East RNA-based Biopharmaceuticals Sales Volume (K Units) by Countries (2013-2018) Table Middle East RNA-based Biopharmaceuticals Sales Volume Market Share by Countries (2013-2018) Figure Middle East RNA-based Biopharmaceuticals Sales Volume Market Share by Countries in 2017 Table Middle East RNA-based Biopharmaceuticals Revenue (Million USD) by Countries (2013-2018) Table Middle East RNA-based Biopharmaceuticals Revenue Market Share by Countries (2013-2018) Figure Middle East RNA-based Biopharmaceuticals Revenue Market Share by Countries (2013-2018) Figure Middle East RNA-based Biopharmaceuticals Revenue Market Share by Countries in 2017 Figure Saudi Arabia RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Israel RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure UAE RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Iran RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Africa RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Africa RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2018) Table Africa RNA-based Biopharmaceuticals Sales (K Units) by Type (2013-2018) Table Africa RNA-based Biopharmaceuticals Sales Market Share by Type (2013-2018) Figure Africa RNA-based Biopharmaceuticals Sales Market Share by Type (2013-2018) Figure Africa RNA-based Biopharmaceuticals Sales Market Share by Type in 2017 Table Africa RNA-based Biopharmaceuticals Sales (K Units) by Application (2013-2018) Table Africa RNA-based Biopharmaceuticals Sales Market Share by Application (2013-2018) Figure Africa RNA-based Biopharmaceuticals Sales Market Share by Application (2013-2018) Table Africa RNA-based Biopharmaceuticals Sales Volume (K Units) by Countries (2013-2018) Table Africa RNA-based Biopharmaceuticals Sales Market Share by Countries (2013-2018) Figure Africa RNA-based Biopharmaceuticals Sales Market Share by Countries (2013-2018) Figure Africa RNA-based Biopharmaceuticals Sales Market Share by Countries in 2017 Table Africa RNA-based Biopharmaceuticals Revenue (Million USD) by Countries (2013-2018) Table Africa RNA-based Biopharmaceuticals Revenue Market Share by Countries (2013-2018) Figure Africa RNA-based Biopharmaceuticals Revenue Market Share by Countries (2013-2018) Figure Africa RNA-based Biopharmaceuticals Revenue Market Share by Countries in 2017 Figure South Africa RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Nigeria RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Egypt RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Algeria RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Table Pfizer RNA-based Biopharmaceuticals Basic Information List Table Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Pfizer RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Pfizer RNA-based Biopharmaceuticals Sales Market Share in EMEA (2013-2018) Figure Pfizer RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2013-2018) Table Roche RNA-based Biopharmaceuticals Basic Information List Table Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Roche RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Roche RNA-based Biopharmaceuticals Sales Market Share in EMEA (2013-2018) Figure Roche RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2013-2018) Table Sanofi-Aventis RNA-based Biopharmaceuticals Basic Information List Table Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Sanofi-Aventis RNA-based Biopharmaceuticals Sales Market Share in EMEA (2013-2018) Figure Sanofi-Aventis RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2013-2018) Table Abbott Laboratories RNA-based Biopharmaceuticals Basic Information List Table Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Abbott Laboratories RNA-based Biopharmaceuticals Sales Market Share in EMEA (2013-2018) Figure Abbott Laboratories RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2013-2018) Table Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Basic Information List Table Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales Market Share in EMEA (2013-2018) Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2013-2018) Table Benitec Biopharma RNA-based Biopharmaceuticals Basic Information List Table Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Benitec Biopharma RNA-based Biopharmaceuticals Sales Market Share in EMEA (2013-2018) Figure Benitec Biopharma RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2013-2018) Table Calimmune Inc RNA-based Biopharmaceuticals Basic Information List Table Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Calimmune Inc RNA-based Biopharmaceuticals Sales Market Share in EMEA (2013-2018) Figure Calimmune Inc RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2013-2018) Table Dicerna RNA-based Biopharmaceuticals Basic Information List Table Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Dicerna RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Dicerna RNA-based Biopharmaceuticals Sales Market Share in EMEA (2013-2018) Figure Dicerna RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2013-2018) Table Gradalis RNA-based Biopharmaceuticals Basic Information List Table Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Gradalis RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Gradalis RNA-based Biopharmaceuticals Sales Market Share in EMEA (2013-2018) Figure Gradalis RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2013-2018) Table Quark RNA-based Biopharmaceuticals Basic Information List Table Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Quark RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2018) Figure Quark RNA-based Biopharmaceuticals Sales Market Share in EMEA (2013-2018) Figure Quark RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2013-2018) Table RXi RNA-based Biopharmaceuticals Basic Information List Table Senesco RNA-based Biopharmaceuticals Basic Information List Table Silence Therapeutics RNA-based Biopharmaceuticals Basic Information List Table Silenseed RNA-based Biopharmaceuticals Basic Information List Table Tekmira RNA-based Biopharmaceuticals Basic Information List Table Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of RNA-based Biopharmaceuticals Figure Manufacturing Process Analysis of RNA-based Biopharmaceuticals Figure RNA-based Biopharmaceuticals Industrial Chain Analysis Table Raw Materials Sources of RNA-based Biopharmaceuticals Major Manufacturers in 2017 Table Major Buyers of RNA-based Biopharmaceuticals Table Distributors/Traders List Figure EMEA RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate Forecast (2018-2025) Figure EMEA RNA-based Biopharmaceuticals Revenue and Growth Rate Forecast (2018-2025) Figure EMEA RNA-based Biopharmaceuticals Price (USD/Unit) and Trend Forecast (2018-2025) Table EMEA RNA-based Biopharmaceuticals Sales (K Units) Forecast by Region (2018-2025) Figure EMEA RNA-based Biopharmaceuticals Sales Market Share Forecast by Region (2018-2025) Table EMEA RNA-based Biopharmaceuticals Revenue (Million USD) Forecast by Region (2018-2025) Figure EMEA RNA-based Biopharmaceuticals Revenue Market Share Forecast by Region (2018-2025) Table Europe RNA-based Biopharmaceuticals Sales (K Units) Forecast by Countries (2018-2025) Figure Europe RNA-based Biopharmaceuticals Sales Market Share Forecast by Countries (2018-2025) Table Europe RNA-based Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2018-2025) Figure Europe RNA-based Biopharmaceuticals Revenue Market Share Forecast by Countries (2018-2025) Table Middle East RNA-based Biopharmaceuticals Sales (K Units) Forecast by Countries (2018-2025) Figure Middle East RNA-based Biopharmaceuticals Sales Market Share Forecast by Countries (2018-2025) Table Middle East RNA-based Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2018-2025) Figure Middle East RNA-based Biopharmaceuticals Revenue Market Share Forecast by Countries (2018-2025) Table Africa RNA-based Biopharmaceuticals Sales (K Units) Forecast by Countries (2018-2025) Figure Africa RNA-based Biopharmaceuticals Sales Market Share Forecast by Countries (2018-2025) Table Africa RNA-based Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2018-2025) Figure Africa RNA-based Biopharmaceuticals Revenue Market Share Forecast by Countries (2018-2025) Table EMEA RNA-based Biopharmaceuticals Sales (K Units) Forecast by Type (2018-2025) Figure EMEA RNA-based Biopharmaceuticals Sales Market Share Forecast by Type (2018-2025) Table EMEA RNA-based Biopharmaceuticals Sales (K Units) Forecast by Application (2018-2025) Figure EMEA RNA-based Biopharmaceuticals Sales Market Share Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources